Hinge Health Raises 2026 Revenue Outlook After Strong Q1 and Platform Expansion

Hinge Health, a leading digital musculoskeletal (MSK) care provider, has raised its full-year revenue outlook by $64 million following a robust first quarter. The company reported first-quarter revenue of $182 million, marking a 47% year-over-year increase from $123.8 million in Q1 2025. Adjusted earnings came in at 45 cents per share, significantly surpassing Wall Street analyst estimates of 12 cents per share. Non-GAAP income from operations surged 208% to $46.2 million, up from $15 million in the same quarter last year.

The company's strong performance and strategic expansion beyond traditional MSK conditions have bolstered investor confidence, with shares climbing approximately 10.5% during after-market trading following the Q1 results.

Business Expansion and Financial Performance

Hinge Health is capitalizing on its success by expanding its digital health platform to address a broader range of chronic conditions. This strategic move aligns with the company's mission to leverage artificial intelligence (AI) and automation to enhance patient outcomes and reduce costs for clients. The expansion includes new offerings for mental health, cardiovascular disease, and diabetes management, further solidifying Hinge Health's position in the digital health market.

Financially, Hinge Health reported several key metrics that highlight its strong performance:

• Billings: Last 12 months billings increased by 52% year-over-year to $769.9 million, up from $507 million.
• Client Base: The company's client base grew by 23% to 2,849 clients as of March 31, 2026, compared to 2,311 clients in the same period last year.
• Free Cash Flow: Free cash flow grew to $41.6 million, a significant increase from $4.2 million in Q1 2025.
• Gross Margin: Both GAAP and non-GAAP gross margins improved to 85%, up from 81% in Q1 2025.

These financial improvements are driven by the company's efficient scaling and investments in AI and automation, which have enhanced operational leverage and service delivery capabilities.

Investment Implications

Hinge Health's strong Q1 performance and expanded business outlook present compelling investment opportunities. The company's updated revenue guidance for 2026 is now set between $798 million and $804 million, reflecting a year-over-year growth of 36% at the midpoint. Non-GAAP income from operations is projected to be between $205 million and $215 million, indicating a 76% year-over-year increase and a non-GAAP operating margin of 26% at the midpoint.

Investors should consider the following key points:

• Revenue Growth: Hinge Health's consistent revenue growth and expanding client base demonstrate strong market demand for its digital health solutions.
• Operational Efficiency: The company's investments in AI and automation are yielding significant operational improvements, as evidenced by the substantial increase in free cash flow and gross margins.
• Market Expansion: The expansion into new chronic conditions represents a strategic move to diversify revenue streams and address a broader patient population.

While Hinge Health's outlook is positive, investors should remain cautious of potential risks such as regulatory changes, increased competition, and the challenges associated with scaling digital health platforms. Nonetheless, the company's robust financial performance and strategic expansion make it an attractive investment in the rapidly growing digital health sector.